Fosaprepitant

In the US, Fosaprepitant (fosaprepitant systemic) is a member of the drug class miscellaneous antiemetics and is used to treat Nausea/Vomiting, Chemotherapy Induced.

US matches:

• Fosaprepitant pimozide


• Fosaprepitant


• Fosaprepitant Intravenous


• Fosaprepitant Dimeglumine

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0172673-20-0

Chemical Formula

C23-H22-F7-N4-O6-P

Molecular Weight

614

Therapeutic Category

Antiemetic

Chemical Name

(3-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid (WHO)

Foreign Names

• Fosaprepitantum (Latin)
• Fosaprepitant (German)
• Fosaprépitant (French)
• Fosaprepitant (Spanish)

Generic Names

• Fosaprepitant Dimeglumine (OS: USAN)
• c-9280 (IS)
• L-758298 (IS)
• MK-0517 (IS: Merck)

Brand Names

• Ivemend
  Merck Sharp & Dohme, Slovenia; MSD, Denmark



• Emend IV
  Merck Sharp & Dohme, Australia



• Ivemend
  Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, France; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Greece; MSD, Switzerland; MSD, Norway

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.